Pathophysiology of Arteriovenous Fistula Maturation and Nonmaturation
- PMID: 36446601
- PMCID: PMC10101610
- DOI: 10.2215/CJN.13101122
Pathophysiology of Arteriovenous Fistula Maturation and Nonmaturation
Conflict of interest statement
M. Gallieni reports consultancy agreements with Vifor Pharma—advisory board for CKD-associated pruritus, BD—CEC committee for clinical studies in the vascular access devices area, and Sanofi Genzyme—Advisory Board, Fabry disease; honoraria as a speaker in meetings, from CME providers, at the national (Italian) and international level—sponsors of such meetings in the past 3 years have been: Amicus, Baxter, BD, Medtronic, Sanofi, and Vifor Pharma; serving as Editor-in-Chief of
Figures
Comment on
-
Association of Shear Stress with Subsequent Lumen Remodeling in Hemodialysis Arteriovenous Fistulas.Clin J Am Soc Nephrol. 2023 Jan 1;18(1):72-83. doi: 10.2215/CJN.04630422. Clin J Am Soc Nephrol. 2023. PMID: 36446600 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources